HAE
Haemonetics Corporation
108.40$
+0.7%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 38.3% | 37.0% | 41.2% | 42.1% | 45.2% | 47.6% | 38.1% | 40.7% | 39.8% | 35.0% | 38.1% | 34.8% | |
| 10.8% | 8.7% | 11.3% | 14.6% | 13.3% | 10.8% | 10.6% | 14.0% | 14.7% | 8.1% | 12.5% | 10.2% | |
| 10.8% | 8.7% | 11.3% | 14.6% | 13.3% | 10.8% | 10.6% | 14.0% | 14.7% | 8.1% | 12.5% | 10.2% | |
| 9.8% | 11.9% | 12.3% | 12.2% | 14.5% | 13.0% | 7.0% | 8.6% | 9.3% | 9.4% | 8.3% | 9.1% | |
| 14.2% | 14.1% | 14.3% | 13.0% | 15.2% | 21.3% | 17.7% | 15.8% | 13.4% | 14.4% | 14.9% | 12.8% | |
| 21.7% | 25.6% | 26.1% | 26.8% | 27.0% | 20.0% | 15.2% | 13.9% | 16.1% | 16.7% | 13.5% | – | |
| 22.5% | 20.3% | 17.0% | 17.1% | 16.5% | 16.6% | 25.6% | 25.1% | 24.1% | 25.7% | 24.7% | 27.4% | |
| 16.5% | 15.5% | 14.3% | 12.7% | 10.0% | 10.5% | 20.1% | 16.7% | 14.3% | 18.5% | 18.6% | 18.7% | |
| 44.3% | 45.3% | 40.3% | 39.2% | 47.6% | 53.7% | 59.8% | 59.7% | 57.7% | 56.3% | 66.5% | 66.8% | |
| 12.7% | 14.0% | 17.0% | 31.1% | 18.5% | 21.7% | 13.9% | 23.8% | 13.0% | 13.7% | 23.6% | 11.8% | |
| 1.5% | 3.3% | 4.9% | 15.7% | 2.2% | 6.7% | 1.4% | 11.9% | 0.6% | 0.5% | 12.4% | 0.2% | |
| 3.3% | 3.0% | 3.5% | 4.5% | 5.0% | 4.0% | 2.8% | 3.1% | 3.3% | 3.3% | 2.7% | 2.1% | |
| 27.4% | 27.7% | 20.5% | 4.8% | 25.3% | 24.1% | 37.9% | 30.1% | 39.0% | 36.3% | 37.6% | 50.9% | |
| 55.7% | 54.7% | 59.7% | 60.8% | 52.4% | 46.3% | 40.2% | 40.3% | 42.3% | 43.7% | 33.5% | 33.2% | |
| 28.3% | 24.0% | 23.4% | 21.6% | 12.7% | 6.2% | 8.7% | 10.9% | 13.1% | 16.4% | 14.4% | 11.7% | |
| 3.5% | 3.9% | 4.2% | 4.3% | 4.2% | 4.1% | 2.8% | 2.8% | 2.7% | 2.3% | 2.1% | 2.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.